Tabula Rasa HealthCare (TRHC) Tops Q2 EPS by 5c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St edges up on AI enthusiasm, Mideast negotiation hopes
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices drop about 3% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Tabula Rasa HealthCare Announces Second Quarter 2018 Operating Results
August 7, 2018 4:06 PM EDTMOORESTOWN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the second quarter ended June 30, 2018.
Tabula Rasa saw another strong quarter financially and operationally, with revenues and Adjusted EBITDA ahead of our guidance, said Calvin H. Knowlton, PhD, TRHCs Chairman and Chief Executive Officer. We continued to expand our footprint in the PACE market, we evolved to meet our partners demands, and we now have an initial plan to implement our medication safety platform... More
